ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 513 filers reported holding ASTRAZENECA PLC in Q4 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $38,913,137 | +206.5% | 498,950 | +166.2% | 0.10% | +229.0% |
Q1 2024 | $12,696,350 | -35.4% | 187,400 | -35.8% | 0.03% | -35.4% |
Q4 2023 | $19,662,361 | +2665.2% | 291,943 | +2680.4% | 0.05% | +2300.0% |
Q3 2023 | $711,060 | -8.3% | 10,500 | -3.0% | 0.00% | 0.0% |
Q2 2023 | $775,032 | +6.3% | 10,829 | +3.1% | 0.00% | 0.0% |
Q1 2023 | $728,805 | -99.5% | 10,500 | -99.5% | 0.00% | -99.6% |
Q4 2022 | $156,196,962 | -41.0% | 2,303,790 | -52.3% | 0.53% | -49.8% |
Q3 2022 | $264,907,000 | +100.7% | 4,830,560 | +141.8% | 1.06% | +89.9% |
Q2 2022 | $132,014,000 | +49.2% | 1,998,079 | +49.8% | 0.56% | +58.7% |
Q1 2022 | $88,484,000 | -14.1% | 1,333,800 | -24.6% | 0.35% | -14.8% |
Q4 2021 | $103,068,000 | -29.6% | 1,769,400 | -27.5% | 0.41% | -35.9% |
Q3 2021 | $146,492,000 | +35.6% | 2,439,088 | +35.2% | 0.64% | +32.3% |
Q2 2021 | $108,061,000 | -38.8% | 1,804,023 | -49.2% | 0.49% | -41.1% |
Q1 2021 | $176,648,000 | -16.6% | 3,552,847 | -16.2% | 0.82% | -20.2% |
Q4 2020 | $211,873,000 | +698.0% | 4,238,298 | +774.8% | 1.03% | +660.3% |
Q3 2020 | $26,550,000 | -27.8% | 484,482 | -30.3% | 0.14% | -43.3% |
Q2 2020 | $36,779,000 | +49.7% | 695,388 | +26.4% | 0.24% | +20.0% |
Q1 2020 | $24,565,000 | -79.6% | 550,049 | -81.1% | 0.20% | -68.2% |
Q2 2019 | $120,137,000 | +26.0% | 2,910,298 | +23.4% | 0.63% | +45.0% |
Q1 2019 | $95,331,000 | +409.6% | 2,357,922 | +378.7% | 0.43% | +375.8% |
Q4 2018 | $18,707,000 | -37.6% | 492,558 | -35.0% | 0.09% | -26.6% |
Q3 2018 | $29,970,000 | -69.5% | 757,400 | -73.0% | 0.12% | -68.4% |
Q2 2018 | $98,380,000 | -3.2% | 2,802,046 | -3.6% | 0.39% | -7.5% |
Q1 2018 | $101,607,000 | +216.5% | 2,905,535 | +214.0% | 0.42% | +205.8% |
Q4 2017 | $32,104,000 | -22.6% | 925,200 | -24.5% | 0.14% | -24.9% |
Q3 2017 | $41,501,000 | +101.9% | 1,224,939 | +103.1% | 0.18% | +60.9% |
Q2 2017 | $20,560,000 | -45.0% | 603,108 | -49.7% | 0.12% | -44.7% |
Q1 2017 | $37,368,000 | +102.3% | 1,200,000 | +77.5% | 0.21% | +61.2% |
Q4 2016 | $18,468,000 | +477.5% | 676,000 | +1246.6% | 0.13% | +486.4% |
Q2 2015 | $3,198,000 | -24.4% | 50,200 | -18.8% | 0.02% | -24.1% |
Q1 2015 | $4,229,000 | -89.8% | 61,800 | -89.5% | 0.03% | -90.0% |
Q4 2014 | $41,341,000 | -42.8% | 587,400 | -41.9% | 0.29% | -46.7% |
Q3 2014 | $72,233,000 | +63.1% | 1,011,100 | +69.7% | 0.54% | +91.5% |
Q2 2014 | $44,274,000 | – | 595,800 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |